Whilst there may well be valid reasons why the organisation chose a fixed percentage of GDP as the goal, it is not immediately clear whether the previous 2 per cent of GDP—or indeed 3 per cent as the UK has recently set as an ambition to be reached during the next parliament—is currently sufficient to maintain a credible level of military effectiveness and even more importantly, whether a fixed percentage of GDP is an appropriate long term metric.
GDP is measured as the market value of all final goods and services produced within an economy over a given period, excluding intermediate goods to avoid double counting. Year-on-year changes in GDP may be attributed to two factors: inflation, reflecting the average rise in prices, and real growth, driven by an increase in the volume of goods and services produced.[1]
Thus, for activities where the overall costs—e.g., wages of the participants and the prices of the goods and services required—increase at below-average rates, a fixed percentage of GDP may well represent a very fair approach to budget setting, as the inflationary increase in GDP will more than cover inflation in the cost of the activity, leaving the balance of that increase and all of the volume driven increase as real budget growth. However, in activities where overall costs consistently rise faster than average, the inflationary component—and potentially all of any volume-driven growth—may be absorbed, resulting in little or no real-terms budget growth.
The economist William J Baumol has written at length on the relative price changes of different economic goods and services. He explains that ‘if the prices of all commodities are not rising at the same pace, then some must be increasing at a rate above average’, which means ‘their inflation-adjusted—or real—prices must be rising’. ‘The list of those items whose real costs are rising remains roughly constant, decade after decade…the items in the rising-cost group generally have a handicraft element—a human element not readily replaceable by machines...which makes it difficult to reduce their labour content.’[2]
His first study on this topic, conducted jointly with Dr Bill Bowen in the 1960s, explored the apparent and persistent rise in the cost of live performing arts—namely theatre, music, and dance—in the United States. To illustrate their argument, the authors envisaged a simplified economy in which workers either manufacture motor vehicles or perform in string trios. Due to increasing productivity, it is possible to reduce the labour effort per motor vehicle by 4 per cent per annum. This means that the auto workers can receive an annual, real terms pay increase of 4 per cent without increasing the labour cost per vehicle. However, if the string trio perform at the same speed, the labour effort involved in a performance will remain constant. In this economy, if the wages of the string players rise at the same rate as those of the auto workers, then the cost per performance will also increase by 4 per cent per annum, as there is no opportunity for productivity improvements.[3]
Let us imagine that these two sectors—automobile manufacturing and live musical performance—are funded from a budget that remains a fixed proportion of GDP. If GDP grows by 2 per cent annually in real terms, the automobile industry, with constant real costs, would receive a 2 per cent annual increase. In contrast, musicians would face a 2 per cent real-terms cut each year, as their costs do not fall in line with productivity gains.
In these two simplified situations, the content of the tasks undertaken by the workers remains static, although the car workers become able to produce the content more quickly. In many industries, technological innovations allow higher-performing products or services to be produced, albeit involving increased complexity, labour content, and cost.
Since the founding of the UK’s National Health Service (NHS) in 1948, there have been major technological advances in diagnostic tests, pharmaceuticals, and medical interventions—contributing, for example, to a doubling of cancer survival rates over the past 50 years. At the same time, the cost of developing new drugs has risen sharply, and the NHS workforce has grown substantially, with ten times as many doctors in 2018 as in 1948.
These cost increases are illustrated in Figure 1. In 1948-49, the NHS consumed 2.4 per cent of GDP, rising to just over 7 per cent before the COVID-19 pandemic.